Sample Sidebar Module

This is a sample module published to the sidebar_top position, using the -sidebar module class suffix. There is also a sidebar_bottom position below the menu.
Login
Register

Sample Sidebar Module

This is a sample module published to the sidebar_bottom position, using the -sidebar module class suffix. There is also a sidebar_top position below the search.
TIME MINS SESSION TITLE PRESENTER

16:00-16:25

25

Registration

16:25-16:30

5

Opening Remarks

Dr Fahad Almohareb
Dr Feras Alfraih

CHAIRPERSON: R. Elfakih

TIME MINS SESSION TITLE PRESENTER

16:30-17:00

30

Biostatistics for Physicians

E. De Vol (KSA)

17:00-17:30

30

Endnote Basics

A. Al-Ghammas (KSA)

17:30-18:00

30

The Challenges of a Career as a Physician Scientist

M. Andreeff (USA)

18:00-18:20

20

Prayer and Coffee Break

CHAIRPERSON: G. Elgohary / O. Khojah

TIME MINS SESSION TITLE PRESENTER

18:20-18:29

55

Molecular Profile of Hemoglobinopathy Mutations in King Khalid University Hospital

N. Almozain

18:29-18:38

55

Acute Chest Syndrome (ACS) is frequently missed and Automated Erythrocytopharesis is more effective in reducing Hb-S and in reversing desaturation

S. Salih

18:38-18:47

55

The Challenging World of Bone Marrow Failure Disorders: Proteomics as Hopeful Molecular Tool Box

A. Alaiya

18:47-18:56

55

Bone marrow fibrosis assessed by Computer-assisted Image analysis (CIA) is associated with poor risk cytogenetics and lower overall survival after allogeneic HSCT for Acute Myeloid Leukemia (AML) and Myelodysplastic syndrome (MDS)

SY. Mohamed

18:56-19:05

55

Allogeneic stem cell transplantation after treatment with program death inhibitors in classical Hodgkin lymphoma is feasible: pooled analysis

R. Dada

19:05-19:15

55

Variable Penetrance in GATA2 Deficiency

A. Seraihi

19:15-19:55

40

Poster Presentation | Prayer and Coffee Break

CHAIRPERSON: H. Alsaedi / K. Ibrahim

TIME MINS SESSION TITLE PRESENTER

19:55-20:04

65

WYE-354 potentiates Adriamycin cytotoxicity in a multidrug resistant acute myeloid leukemia cell line model

S. Ibrahim

20:04-20:13

65

Prognostic Implications of Notch 1 Expression Among Adult Patients with Normal Cytogenetic Acute Myeloid Leukemia

G. Elyamany

20:13-20:22

65

Correlation between the killer cell immunoglobulin-like receptor AA haplotype and childhood acute lymphoblastic leukemia in Saudis

A. Osman

20:22-20:31

65

Phase 2 study of 5 days azacytidine priming prior to fludarabine, Cytarabine and G-CSF combination for patients with relapsed or refractory AML

I. Motabi

20:31-20:40

65

Retrospective analysis of Five-year survival of adult patients with chronic lymphocytic leukemia treated via first line chemotherapy at princess Noorah Oncology Center – King Abdulaziz Medical City – Jeddah from 2000 to 2016

M. Adam

20:40-20:49

65

Outpatient-Based High Dose Cytarabine for Patients with Acute Myeloid Leukemia: Safe, Feasible and Cost Effective Approach

E. Alshaibani

20:49-21:00

65

Outcomes of t(8;21) Are Not Different From Intermediate Risk AML in A Cohort Of Young Patients From The Middle East : A Single Center Study of KFSHRC Riyadh

S. Alhumaid

21:00-21:15

15

Awards

Dr Fahad Almohareb

21:15-21:20

5

Closing Remarks

Dr Feras Alfraih

21:20-22:30

70

Dinner